COMP <GO>
PACS vs EHC // EV/EBITDA & P/E VALUATION
PACS Group Inc. (NYSE) VS. Encompass Health Corporation (NYSE) • 15-METRIC TALLY: PACS 5
— EHC 7
▲ EV/EBITDA & P/E VALUATION LEADER: PACS
LAST: $47.81 (-3.76%) • MKT CAP: $7.87B
valuation
15.5x
LAST: $135.90 (+3.35%) • MKT CAP: $12.97B
valuation
15.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PACS VS. EHC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PACS | EHC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.60% | 13.80% | +10.80 | PACS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 15.5x | 15.8x | -0.30 | PACS | /valuation <GO> |
| Free Cash Flow Yield | 2.11% | 2.92% | -0.81 | EHC | /fcf-yield <GO> |
| Operating Margin | 5.90% | 11.60% | -5.70 | EHC | /operating-margins <GO> |
| Net Profit Margin | 3.60% | 9.50% | -5.90 | EHC | /net-margins <GO> |
| Revenue Growth (YoY) | 29.40% | 10.50% | +18.90 | PACS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.55% | -0.55 | EHC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.24 | 3.47 | -1.23 | EHC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.4 | 60.3 | +3.10 | PACS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.90 | +0.05 | PACS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.5x | 21.3x | +13.20 | EHC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.87B | $12.97B | -$5.11B | EHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PACS REV | EHC REV | PACS GROSS % | EHC GROSS % | PACS FCF | EHC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.29B | $5.94B | — | — | $166.3M | — |
| FY 2024 | $4.09B | $5.37B | — | — | $183.4M | — |
| FY 2023 | $3.11B | $4.80B | — | — | -$76.3M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PACS // BETA 0.95
EHC // BETA 0.90